Is the product suitable for self-administration?

No, it should be administered by a doctor or a nurse; do not self-administer at home.

What is the lead time for production?

The average lead time is 1-3 months for both peak and off-peak seasons.

Ranitidine Hydrochloride HCl Injection 50mg: 2ml for Acid Suppressant/Heartburn Relief

Name: Ranitidine Hydrochloride HCl Injection 50mg: 2ml for Acid Suppressant/Heartburn Relief
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 2194676895

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.01

20,000-99,999 Pieces

US$0.0001

100,000+ Pieces

Product profile

Customization

Available

Application

Digestive System

Usage Mode

Model NO.

50mg/2ml

Suitable for

Adult

State

Liquid

Shape

Small-Volume Injection

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

SL2022001

Drug Ad Approval No.

SL2022001

Test Repot

Available

Period of Validity

3 Years

Authentication

GMP

Register Dossier

Available

Quality Standard

Bp or USP

Customized

According to Your Requirement

Appearance

Powder

Transport Package

Carton Box

Specification

30mg

Trademark

shenglu

Origin

Shandong China

HS Code

3001909099

Production Capacity

1 Billion /Year

Key features

GMP Certified Production: Manufactured under strict GMP standards ensuring high quality and safety.

3 Years Validity Period: Product maintains efficacy and stability for up to 3 years from manufacture.

BP2024 Quality Standard: Meets British Pharmacopoeia 2024 specifications for purity and potency.

Full Customization Available: Offers full customization, minor customization, and customization from designs.

100% Finished Product Inspection: Every batch undergoes visual and functional inspection before release.

OEM and ODM Services: Provides both OEM and ODM services to meet specific client requirements.

Acid Suppression Therapy: Effectively treats stomach acid overproduction and ulcers in hospitalized patients.

Fast Relief from Heartburn: Provides relief from indigestion and heartburn within a few hours of administration.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity100% Finished Products Inspection

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤15h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.